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Knee arthroscopyAbstract Aim: To evaluate efﬁciency of dexmedetomidine compared to fentanyl as supplements
to low-dose levobupivacaine spinal anesthesia in patients undergoing knee arthroscopy.
Materials and methods: Sixty adult patients (ASA I or II) scheduled for knee arthroscopy were ran-
domized to receive plain levobupivacaine (4 mg) plus dexmedetomidine (3 lg) in group D or fenta-
nyl (10 lg) in group F.
Results: Dexmedetomidine shortened time to surgery (P= 0.002), time to highest sensory level
(P= 0.001), and time to highest Bromage score (P< 0.001). The highest sensory level was compa-
rable in both groups (P= 0.969), but the duration of sensory block was signiﬁcantly longer in
group D (P= 0.009). The highest Bromage score was 2 in both groups. This score was attained
in signiﬁcant higher number of patients in group D (P= 0.038) that showed better muscular relax-
ation (P= 0.035). At the end of surgery, a residual motor block (Bromage score 1) was observed in
signiﬁcant higher number of patients (P= 0.033) and time to ambulation was signiﬁcantly longer in
group D (P= 0.001). There was no difference in the number of patients bypassed post-anesthesia
care unit (PACU) (P= 0.761) or time to hospital discharge (P= 0.357) between groups. The pain
free period was more prolonged (P< 0.001), and the visual analog scale (VAS) for pain was lower
at the 2nd, 4th, 6th, and 8th postoperative hours (P< 0.001, <0.001, 0.013, 0.030 respectively) in
group D.
150 A.S. Basuni, H.A.A. EzzConclusion: Dexmedetomidine is a good alternative to fentanyl for supplementation of low-dose
levobupivacaine spinal anesthesia for knee arthroscopy.
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Spinal anesthesia provides an excellent mean of postoperative
pain control following ambulatory procedures [1]; however,
these advantages may be offset by an increased likelihood of
delayed recovery of motor power and, hence, delayed ambula-
tion and prolonged hospital stay [2,3]. The development of the
‘‘low-dose spinal’’ technique involving the use of low-doses of
local anesthetics, often in association with fentanyl, improved
the utility of spinal anesthesia in ambulatory surgical setting
through increasing the sensory without increasing motor block
or time to micturition. Nevertheless, inadequate anesthesia
and risks of intrathecal opioids still remain the main problems
of this technique [4,5].
Intrathecal a2-adrenoceptor agonists as adjuvant drugs
have been shown to decrease the required doses of local anes-
thetics [6,7]. Dexmedetomidine is highly selective a2-adreno-
ceptor agonists. It potentiates local anesthetics effects,
prolongs postoperative analgesia, and has a dose-dependent
sedative effect without respiratory depression [8]. The mecha-
nism of action of intrathecal a2-adrenoceptor agonists is not
well understood; they may have an additive or synergistic ef-
fect to local anesthetics through binding to the pre-synaptic
C-ﬁbers and postsynaptic dorsal horn neurons producing anal-
gesia by depressing the release of C-ﬁber neurotransmitters
and hyperpolarization of postsynaptic dorsal horn cells
[9,10]. The prolongation of motor block of spinal anesthetics
may result from hyperpolarization of ventral horn motoneu-
rons of the spinal cord that facilitate local anesthetic action
[11].
The purpose of the present study is to evaluate efﬁciency of
low-dose dexmedetomidine compared to fentanyl as supple-
ments to low-dose levobupivacaine spinal anesthesia in
patients undergoing knee arthroscopy.
2. Materials and methods
After obtaining an institutional review board approval (code
number: 1901) and written informed consent, 60 consecutive
adult patients (ASA I or II) of both sexes scheduled for day
case knee arthroscopy by the same surgeon were included in
this prospective, randomized, double-blind study. Uncoopera-
tive patients and those with diabetes mellitus, body mass index
>35 kg/m2, height <150 cm or >185 cm, contraindication to
spinal anesthesia, allergy to amide type local anesthetics, or
history of chronic analgesic therapy were excluded from the
study.
Patients were randomized using a computer generated ran-
dom numbers table into groups: D and F; 30 patients each.
Allocation to each group was concealed using opaque sealed
sequentially numbered envelopes. All patients received 4 mg
plain levobupivacaine [Chirocaine, Abbot Laboratories;
5 mg/ml] combined with 3 lg dexmedetomidine (Precedex,
Hospira, USA; 100 lg/ml) in group D, or 10 lg fentanyl (Fen-
tanyl, Hameln pharmaceutical gmbh, Germany, 50 lg/ml) ingroup F. The spinal solutions were prepared by an anesthesi-
ologist, who was blinded to the study, to a total volume of
3 ml with sterile water. The patient, surgeon, and anesthesiol-
ogist who performed the block and recorded the data were
blind to the study solutions. Before lumbar puncture, the pa-
tients were monitored for electrocardiography, pulse oximetry,
and non-invasive blood pressure. They were preloaded with
Ringer’s solution (250 ml) followed by an infusion of 2 ml/
kg/h. Lumber puncture was performed in the sitting position
at L4–5 or L3–4 using a midline approach with a 25-G spinal
needle with the hole pointing upwards. The spinal solutions
were injected over 10 s with no barbotage followed by placing
the patients in the supine position. In case of intraoperative
discomfort or pain, they were administered general anesthesia
and excluded from the study. The sensory and motor blocks
were assessed every 2 min till their upper levels were attained,
and then every 15 min till they returned to normal. The sensory
block was tested bilaterally along the mid-clavicular lines by
pin prick, while the motor block was assessed according to
the Bromage scale (0: no motor loss, 1: inability to ﬂex hip
joint, 2: inability to ﬂex knee joint, 3: inability to ﬂex ankle).
When no motor block could be detected (Bromage scale 0)
and when the patients were ready, they were asked to walk.
At the end of surgery, the patients were bypassed the post-
anesthesia care unit (PACU), if PACU bypass score was 10
[12], no pain, nausea, vomiting, pruritus, or shivering [13]. In
the ambulatory surgery unit, they were discharged home when
the Post-Anesthetic Discharge Scoring System was P9 [14].
The times to surgery (loss of pin prick sensation at T12),
highest sensory level, highest Bromage score, ambulation,
and hospital discharge measured from intrathecal injection
were determined. The highest sensory level, duration of sen-
sory blockade (measured from intrathecal injection till regres-
sion of the sensory level to S1), highest Bromage score,
Bromage score at end of surgery, intraoperative adequacy of
muscular relaxation evaluated as good or poor by the surgeon,
intraoperative level of sedation according to Ramsay sedation
score [15], number of patients bypassed the PACU, and side
effects including nausea, vomiting, shivering, respiratory
depression (oxygen saturation <96% and respiratory rate
<10/min), hypotension (mean arterial blood pressure <20%
of preoperative value or systolic blood pressure less than
100 mmHg; treated by increasing the ﬂuid infusion rate and
IV 3–6 mg ephedrine), bradycardia (heart rate <50/min; trea-
ted by IV 0.6 mg atropine) were recorded.
The patients were contacted by telephone, after discharging
home, in order to determine the pain free period (measured
from intrathecal injection to the ﬁrst analgesic requirement)
and the severity of pain according to a visual analog scale
(VAS: 0–10) at the following times: 1st, 2nd, 4th, 6th, 8th,
10th, and 12th postoperative hour. Rescue analgesia, oral dic-
lofenac sodium 50 mg/12 h, was started when the VAS was
P3.
The sample size was estimated using data from a previous
pilot study performed at our institution. A difference of
7 min in the mean (M) value of times to ambulation between
Dexmedetomidine as Supplement to Low-dose Levobupivacaine Spinal Anesthesia for Knee Arthroscopy 151the two groups and a standard deviation (SD) of 9 was used
for calculation. Twenty-six patients were required per group
using a cutoff for statistical signiﬁcance of 0.05% and a power
of 80%. Thirty patients per group were included. Data were
analyzed using SPSS (version 20) for windows and presented
as M± SD, median (range), or number (%) where appropri-
ate. Independent t-test was used for comparison of age, weight,
height, body mass index (BMI), surgery time, time to surgery,
the duration of sensory block, time to highest Bromage score,
time to ambulation, time to hospital discharge, and the pain
free period. Mann–Whitney U test was used for analysis of
the highest sensory level and the VAS values. Fisher’s exact
test was used for comparison of gender, ASA status, the high-
est Bromage score, Bromage score at end of surgery, adequacy
of relaxation, and the number of patients bypassed PACU.
P< 0.05 was considered statistically signiﬁcant.
3. Results
The spinal technique was easy and uneventful in all patients.
One patient was administered general anesthesia and excluded
after recruitment because of intraoperative pain complaint
after successful intrathecal injection, leaving 29 patients, in
group F. Therefore, the statistical analyses were based on 29
patients in the dexmedetomidine group and 30 patients in
the fentanyl group. Demographic data (Table 1) were compa-
rable in both groups (P< 0.05).
As shown in Table 2, intrathecal dexmedetomidine fastened
the time to surgery (onset of neuraxial block) (P= 0.002), time
to highest sensory level (P= 0.001), and time to highest Bro-
mage score (P< 0.001). The highest sensory level was compa-
rable in both groups (P= 0.969), but the duration of sensory
blockade was signiﬁcantly longer in group D than group F
(P= 0.009). The intensity of motor block was superior in the
dexmedetomidine group. Although the highest Bromage score
was 2 in both groups, this score was attained in signiﬁcant high-
er number of patients in dexmedetomidine group compared to
fentanyl group (19 vs. 10 patients; P= 0.038). At the end of
surgery, the Bromage score equaled 1 in signiﬁcant higher num-
ber of patients in group D (16 vs. 7 patients in groups D and F
respectively; P= 0.033) and the adequacy of muscular relaxa-
tion as evaluated by the surgeon (good in 22 vs. 13 patients in
groups D and F respectively; P= 0.035) were signiﬁcantly bet-
ter in group D. There was no signiﬁcant difference between the
number of patients who bypassed the PACU (22 vs. 23 patients
in groups D and F respectively; P= 0.761). The time to
ambulation was signiﬁcantly longer in group D (the mean dif-
ference equaled 9.1 ± 2.7 min; P= 0.001), and there was noTable 1 Demographic data.
Variables Group F no = 29
Age; year 40.1 ± 6.1
Weight; kg 81.3 ± 7.4
Height; cm 176.7 ± 3.9
BMI; m/kg2 26 ± 1.8
Gender; male/female 14/15
ASA; I/II 19/10
Surgery time; min 55.1 ± 11.4signiﬁcant difference between groups concerning the time to
discharge from hospital (P= 0.357).
The pain free period was signiﬁcantly longer in group D
(P< 0.001), and the VAS was signiﬁcantly lower in dexmede-
tomidine than fentanyl groups at the 2nd, 4th, 6th, and 8th
postoperative hours (P< 0.001, <0.001, 0.013, 0.030 respec-
tively) (Table 3).
None of patients developed nausea, vomiting, shivering,
pruritus, or respiratory depression. Only two patients devel-
oped intraoperative hypotension in group F, and one devel-
oped bradycardia in group D; and they were managed
successfully. One patient in group F fell asleep during surgery
and was easily aroused by simple verbal command (Ramsay
sedation score 2).
4. Discussion
This is the ﬁrst study testing intrathecal levobupivacaine in
association with dexmedetomidine for knee arthroscopy. In
comparison with intrathecal fentanyl adjuvant, dexmedetomi-
dine fastened the onset of spinal anesthesia; it prolonged and
intensiﬁed levobupivacaine sensory and motor blocks.
Although the time to ambulation was increased (the mean dif-
ference between the groups equaled 9.1 ± 2.7 min), it did not
affect the ratio of patients who bypassed the PACU or the time
to discharge home. Dexmedetomidine prolonged the pain free
period and improved postoperative analgesia. Different studies
[8,16–18] are consistent with these ﬁndings.
In the present study, although the statistically signiﬁcant
difference in the anesthetic characteristics, particularly the
duration of sensory and motor blocks, between the groups
are really insubstantial, this is likely to be advantageous in
knee arthroscopic surgery that requires early ambulation and
discharge. Kanazi et al. [16], showed dexmedetomidine poten-
tiates the anesthetic characteristics of hyperbaric bupivacaine
without serious side effects in patients undergoing transure-
thral resection of prostate or bladder tumor. Dexmedetomi-
dine produced valuable differences in the duration of sensory
and motor blocks (averaged 100 and 90 min; respectively) be-
tween patients received bupivacaine (12 mg) and those received
bupivacaine (12 mg) and dexmedetomidine (3 lg) which is con-
tradictory to our results. However, this could be attributed to
the use of low-dose of local anesthetic in our study (4 mg of
levobupivacaine).
Levobupivacaine and bupivacaine are equally effective
local anesthetics for spinal anesthesia; however, the decreased
cardiovascular and central nervous system toxicity make levo-
bupivacaine an interesting choice for spinal anesthesia despiteGroup D no = 30 p
39.1 ± 5.5 0.481
79.4 ± 7.2 0.319
175.8 ± 4.5 0.385
25.7 ± 1.9 0.592
17/13 0.606
18/12 0.789
52.8 ± 10.9 0.443
Table 2 Anesthetic characteristics’.
Variables Group F no = 29 Group D no = 30 P
Time to surgery; min 5.1 ± 1.5 3.9 ± 1.2* 0.002
Highest sensory levela T8 (6–11) T8 (5–11) 0.969
Time to highest sensory level; min 13.8 ± 4.4 10.7 ± 2.3* 0.001
Duration of sensory blockade; min 64.9 ± 11.3 73.9 ± 13.9* 0.009
Highest Bromage score (0/1/2/3); n 0/19/10/0 0/11/19/0* 0.038
Time to highest Bromage score; min 18.9 ± 4.1 14.1 ± 2.3* <0.001
Bromage score at end of surgery (0/1/2/3); n 22/7/0/0 14/16/0/0* 0.033
Adequacy of relaxation (good/poor); n 13/16 22/8* 0.035
Patients bypassed PACU; n% 23(79.3%) 22(73.3%) 0.761
Time to ambulation; min 64.2 ± 11.9 73.3 ± 8.5* 0.001
Pain free period; min 70.2 ± 8.4 126.6 ± 12.9* <0.001
Time to hospital discharge; min 254 ± 19.3 266 ± 25.2 0.357
a Data presented as Median (range).
* Statistically signiﬁcant difference (P< 0.05).
Table 3 VAS scale scores.
VAS 1 VAS 2 VAS 4 VAS 6 VAS 8 VAS 10 VAS 12
Group F no = 29 0 (0–0) 2 (0–4) 3 (1–5) 3 (1–4) 4 (2–5) 4 (3–5) 4 (3–6)
Group D no = 30 0 (0–0) 0 (0–0)* 2 (1–4)* 2 (1–5)* 3 (3–4)* 4 (3–5) 4 (3–6)
P 1.00 <0.001 <0.001 0.013 0.030 0.236 0.473
Data presented as Median (range).
* Statistically signiﬁcant difference (P< 0.05).
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regimens compared to epidural anesthesia [19,20]. A recent re-
view of spinal anesthesia for knee arthroscopy demonstrated
that bupivacaine in doses as low as 4–5 mg given in the spine
position was associated with a failure rate of 25% due to
inadequate anesthesia. Low-dose bupivacaine can produce en-
ough anesthesia with no or very low incidence of failure for
knee arthroscopy, only, when hyperbaric bupivacaine is used,
along with the unilateral positioning and intrathecal fentanyl
[21]. Unfortunately, the unilateral spinal anesthesia added an
extra time (10–15 min) required for the local anesthetic to ﬁx
[22,23]; and intrathecal fentanyl in dose of 10–25 lg produced
an incidence of pruritus of 48–75% [4,24–26]. Moreover, there
are reports that spinal anesthesia with plain local anesthetic
has rapid onset, longer duration of action but lower height
of blockade, and less cardiovascular disturbances [27,28]. Dex-
medetomidine, in the present study, avoided the drawbacks of
the unilateral position and intrathecal fentanyl, while preserv-
ing the beneﬁts of plain levobupivacaine.
De Santiago et al. [13] tested three doses of plain levobup-
ivacaine (3, 4, and 5 mg) in association with fentanyl 10 lg
given in the supine position for knee arthroscopy. They
showed that 4 mg is the ideal dose of intrathecal levobupiva-
caine. It was associated with the shortest time to ambulation,
highest PACU bypass rate, fewer patients presented with al-
tered proprioception, and higher rate of unassisted ambulation
at the end of surgery. However, they reported a probability of
spinal failure (0.5%) because of inadequate block with levo-
bupivacaine in doses of 4 or 5 mg. Similar incidences of failure
(5–10%) were seen in obstetric surgical patients [29]. Our trail
showed a failure rate of 3% in levobupivacaine–fentanylgroup compared to no failure in levobupivacaine–dexmede-
tomidine group. Weighing the capability of dexmedetomidine
adjuvant to intensify anesthesia and improve postoperative
pain control against the increase in motor block suggests that
dexmedetomidine is a good alternative to fentanyl for supple-
mentation of low-dose spinal anesthesia. The dexmedetomi-
dine-associated increase in motor block could be beneﬁcial in
anxious less cooperative patients and those who require sur-
gery of longer time.
The results of the current study are limited by the lack of
United State Food and Drug Administration approval for
the perineural application of dexmedetomidine because of
doubts about its neurotoxicity that resulted in scant appear-
ance of trails on this topic [30]. Indeed, relevant neurotoxicity
data seem contradictory, while dexmedetomidine has been
shown to cause moderate to severe demyelination in white
matter when doses as high as 6.1 lg/kg were administered
via an epidural route in rabbit [31], intrathecal dexmedetomi-
dine (2.5–100 lg) produced no neurological deﬁcits in sheeps
[32], and epidural dexmedetomidine (1.5–2 lg/kg) caused no
neurological deﬁcits in humans [33,34]. In a systematic review
by Abdallah and Brull [30], dexmedetomidine in doses up to
0.2 lg/kg for intrathecal and 1 lg/kg for perineural peripheral
administration potentiated local anesthetics effects without
producing any neurotoxic manifestations.
In conclusion, intrathecal dexmedetomidine 3 lg plus
levobupivacaine 4 mg improves the quality of anesthesia and
postoperative analgesia for knee arthroscopy. Low-dose
dexmedetomidine is a good alternative to fentanyl for
supplementation of spinal anesthesia in ambulatory surgical
setting.
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